Covid-19 roundup: EU cracks down fur­ther on vac­cine ex­ports; Pfiz­er en­ters race for Covid-19 pill

Eu­rope is lock­ing down its bor­ders again.

Strug­gling to in­oc­u­late its pop­u­la­tion while the UK and US steam­roll ahead, the Eu­ro­pean Union is fi­nal­iz­ing leg­is­la­tion that would give it broad pow­er to pre­vent vac­cines pro­duced in its bor­ders from leav­ing its bor­ders for six weeks, The New York Times re­port­ed.

The crack­down on ex­ports could most se­vere­ly im­pact the UK. The for­mer EU mem­ber state con­tract­ed with As­traZeneca and lat­er Pfiz­er and BioN­Tech to buy mil­lions of dos­es that are pro­duced on the con­ti­nent — dos­es they’ve been re­ly­ing on to now vac­ci­nate 40% of its pop­u­la­tion. On­ly about 10% of the EU’s pop­u­la­tion have re­ceived shots.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN